In the News: Investors Turn to Invest in China's Secondary PE Market; Mad Dash for Chinese AI Pharma IPO; and China Issues New Carbon Emissions Measures

June 11, 2024 | BY

Krista Lee

International investors find Chinese secondary PE market an alternative amid U.S.-China tensions; QuantumPharm is the first IPO under Hong Kong's new measure for pre-revenue specialist technology firms; and China releases new carbon measuring standards foreseeing new EU carbon tariffs.

Secondary PE Market an Easier Way to Invest in China

Amid U.S.-China tensions and a market slump that has led to declining valuations, international investors are interested in gaining exposure